- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Curatis Holding AG (CURN)
Curatis Holding AG stock price live, this page displays SIX CURN stock exchange data. View the CURN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Curatis Holding AG real time stock price chart below.
What Is the Curatis Holding AG Stock Price Today?
The Curatis Holding AG stock price today is 19,1500.
What Is the Stock Symbol for Curatis Holding AG?
The stock symbol for Curatis Holding AG is "CURN."
What Stock Exchange Does Curatis Holding AG Trade On?
Curatis Holding AG is listed and trades on the Switzerland stock exchange.
Is Curatis Holding AG a Good Stock to Buy?
Determining whether Curatis Holding AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CURN quote. (ISIN: CH1330780979)
What Is the Curatis Holding AG Stock Price Today?
The Curatis Holding AG stock price today is 19,1500.
What Is the Stock Symbol for Curatis Holding AG?
The stock symbol for Curatis Holding AG is "CURN."
What Stock Exchange Does Curatis Holding AG Trade On?
Curatis Holding AG is listed and trades on the Switzerland stock exchange.
Is Curatis Holding AG a Good Stock to Buy?
Determining whether Curatis Holding AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CURN quote. (ISIN: CH1330780979)
Switzerland
Currency in CHF
19.1500
+0.6500(+3.51%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.9500
19.9000
52 wk Range
11.0500
27.9000
CURN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.950019.9000
52 wk Range
11.050027.9000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CURN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
Mar 24, 2026
EPS / Forecast
-0,05 / --
Revenue / Forecast
5,56M / --
Compare CURN to Peers and Sector
Metrics to compare | CURN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCURNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −73.0x | −3.2x | −0.4x | |
PEG Ratio | −0.88 | −0.03 | 0.00 | |
Price/Book | 2.2x | 1.0x | 2.6x | |
Price / LTM Sales | 9.6x | 3.7x | 3.0x | |
Upside (Analyst Target) | - | 47.7% | 54.2% | |
Fair Value Upside | Unlock | 8.9% | 6.4% | Unlock |
Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of fentanyl, breakthrough pain, antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collagen sponge, benign prostatic hyperplasia, immunomodulator, epilepsy and essential tremor, thyreostatic, hereditary tyrosinemia type 1, nootropic, tranquilizer, helicobacter pylori test, phosphate binder, special nutrition for dialysis patients, dermato corticosteroid, lead and mercury poisoning, corticostimulin, anti-fog agent, chorea associated with huntington’s disease, and antiepileptic. The company also develops C-PTBE-01, which is in Phase IIb clinical trial for the treatment of peritumoral brain edema; C-AM-01 that is in Phase IIa clinical trial for the prevention of severe migraine with aura; C-MOH-01, which is in Phase IIa clinical trial for the treatment and prevention of medication overuse headache; and C-FI-01 that is in phase I clinical trial for the treatment of fibrotic or inflammatory orphan or ultra-orphan diseases. The company was founded in 2002 and is based in Liestal, Switzerland.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Curatis Holding (CURN) Stock Price Today?
The Curatis Holding stock price today is 19,1500 CHF.
What Stock Exchange Does Curatis Holding Trade On?
Curatis Holding is listed and trades on the Switzerland Stock Exchange.
What Is the Stock Symbol for Curatis Holding?
The stock symbol for Curatis Holding is "CURN."
What Is the Curatis Holding Market Cap?
As of today, Curatis Holding market cap is 103,0800M CHF.
What Is Curatis Holding's Earnings Per Share (TTM)?
The Curatis Holding EPS (TTM) is -0,2839.
From a Technical Analysis Perspective, Is CURN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Curatis Holding Stock Split?
Curatis Holding has split 1 times.
How Many Employees Does Curatis Holding Have?
Curatis Holding has 9 employees.
What is the current trading status of Curatis Holding (CURN)?
As of Sep 22, 2026, Curatis Holding (CURN) is trading at a price of 19,1500 CHF, with a previous close of 18,5000 CHF. The stock has fluctuated within a day range of 18,9500 CHF to 19,9000 CHF, while its 52-week range spans from 11,0500 CHF to 27,9000 CHF.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.